Malignant Mesothelioma of the Inguinal Canal With an Unusually Long Survival

od Walshe, Janice M., Gal, Anthony, Murray, Douglas R., Premkumar, Ahalya, Berman, David, Hassan, Raffit
Wydane w Am J Clin Oncol (2008)

Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with trastuzumab-insensitive HER2-positive metastatic breast cancer

od Portera, Chia C., Walshe, Janice M., Rosing, Douglas R., Denduluri, Neelima, Berman, Arlene W., Vatas, Ujala, Velarde, Margarita, Chow, Catherine K., Steinberg, Seth M., Nguyen, Diana, Yang, Sherry X., Swain, Sandra M.
Wydane w Clin Cancer Res (2008)

Impact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the “one thousand HER2 patients” project

od Gullo, Giuseppe, Walsh, Naomi, Fennelly, David, Bose, Reetesh, Walshe, Janice, Tryfonopoulos, Dimitrios, O’Mahony, Kate, Hammond, Lisa, Silva, Nuno, McDonnell, Deirdre, Ballot, Josephine, Quinn, Cecily, McDermott, Enda W., Evoy, Denis, Prichard, Ruth, Geraghty, James, Amstrong, John, Crown, John
Wydane w Br J Cancer (2018)

Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2...

od Rakha, Emad A., Miligy, Islam M., Quinn, Cecily M., Provenzano, Elena, Shaaban, Abeer M., Marchiò, Caterina, Toss, Michael S., Gallagy, Grace, Murray, Ciara, Walshe, Janice, Katayama, Ayaka, Eldib, Karim, Badr, Nahla, Tanchel, Bruce, Millican-Slater, Rebecca, Purdie, Colin, Purnell, Dave, Pinder, Sarah E., Ellis, Ian O., Lee, Andrew H. S.
Wydane w Br J Cancer (2021)

Understanding and Attitudes toward Cancer Clinical Trials among Patients with a Cancer Diagnosis: National Study through Cancer Trials Ireland

od Kearns, Cathriona, Feighery, Ronan, Mc Caffrey, John, Higgins, Michaela, Smith, Martina, Murphy, Verena, O’Reilly, Seamus, Horgan, Anne M., Walshe, Janice, McDermott, Ray, Morris, Patrick G., Keane, Maccon, Martin, Michael, Murphy, Conleth, Duffy, Karen, Mihai, Alina, Armstrong, John, O’Donnell, Dearbhaile M., Gallagher, William M., Kelly, Ciara M., Kelly, Catherine M.
Wydane w Cancers (Basel) (2020)

Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted ther...

od Toomey, Sinead, Eustace, Alexander J., Fay, Joanna, Sheehan, Katherine M., Carr, Aoife, Milewska, Malgorzata, Madden, Stephen F., Teiserskiene, Ausra, Kay, Elaine W., O’Donovan, Norma, Gallagher, William, Grogan, Liam, Breathnach, Oscar, Walshe, Janice, Kelly, Catherine, Moulton, Brian, Kennedy, M. John, Gullo, Guiseppe, Hill, Arnold D., Power, Colm, Duke, Deirdre, Hambly, Niamh, Crown, John, Hennessy, Bryan T.
Wydane w Breast Cancer Res (2017)

A randomized trial of five years of letrozole versus placebo after aromatase inhibitor-based therapy: NRG Oncology/NSABP B-42

od Mamounas, Eleftherios P., Bandos, Hanna, Lembersky, Barry C., Jeong, Jong-Hyeon, Geyer, Charles E., Rastogi, Priya, Fehrenbacher, Louis, Graham, Mark L., Chia, Stephen K., Brufsky, Adam M., Walshe, Janice M., Soori, Gamini S., Dakhil, Shaker R., Seay, Thomas E., Wade, James L., McCarron, Edward C., Paik, Soonmyung, Swain, Sandra M., Lawrence Wickerham, D., Wolmark, Norman
Wydane w Lancet Oncol (2018)

Phase Ib Trial of Copanlisib, A Phosphoinositide-3 Kinase (PI3K) Inhibitor, with Trastuzumab in Advanced Pre-Treated HER2-Positive Breast Cancer “PantHER”

od Keegan, Niamh M., Furney, Simon J., Walshe, Janice M., Gullo, Giuseppe, Kennedy, M. John, Smith, Diarmuid, McCaffrey, John, Kelly, Catherine M., Egan, Keith, Kerr, Jennifer, Given, Mark, O’Donovan, Peter, Hernando, Andres, Teiserskiene, Ausra, Parker, Imelda, Kay, Elaine, Farrelly, Angela, Carr, Aoife, Calzaferri, Giulio, McDermott, Ray, Keane, Maccon M., Grogan, Liam, Breathnach, Oscar, Morris, Patrick G., Toomey, Sinead, Hennessy, Bryan T.
Wydane w Cancers (Basel) (2021)

Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis o...

od Gullo, Giuseppe, J. Eustace, Alex, Canonici, Alexandra, M. Collins, Denis, Kennedy, Michael J., Grogan, Liam, Breathhnach, Oscar, McCaffrey, John, Keane, Maccon, Martin, Michael J., Gupta, Rajnish, Leonard, Gregory, O’Connor, Miriam, Calvert, Paula M., Donnellan, Paul, Walshe, Janice, McDermott, Enda, Scott, Kathleen, Hernando, Andres, Parker, Imelda, W. Murray, David, C. O’Farrell, Alice, Maratha, Ashwini, Dicker, Patrick, Rafferty, Mairin, Murphy, Verena, O’Donovan, Norma, M. Gallagher, William, Ky, Bonnie, Tryfonopoulos, Dimitrios, Moulton, Brian, T. Byrne, Annette, Crown, John
Wydane w Ther Adv Med Oncol (2019)